𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical experience with sorbinil—An aldose reductase inhibitor

✍ Scribed by Norman E. Pitts; Franzanne Vreeland; Gerald L. Shaw; Michael J. Peterson; Dilip J. Mehta; John Collier; K. Gundersen

Book ID
118949279
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
521 KB
Volume
35
Category
Article
ISSN
1532-8600

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and neurophysiological studies
Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy
✍ I. G. Lewin; I. A. D. O'Brien; M. H. Morgan; R. J. M. Corrall 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 436 KB

The effect of sorbinil (200 mg daily for 4 weeks) was examined in 13 patients, mean age 59.7 years (range 42-72 years), with symptomatic diabetic neuropathy of mean duration 6 year (range 1-18 years). In this double-blind, placebo-controlled crossover trial, studies were made of motor, sensory and a